The gel layer creates a hydrated barrier around the dosage form after gastrointestinal fluid enters the polymer. Drug that has dissolved inside the matrix must pass through this layer before entering surrounding fluid. Because the layer moderates movement outward, it can slow diffusion and extend drug release compared with immediate exposure of the drug to gastrointestinal fluid.
These processes contribute in sequence and may overlap. Water uptake hydrates the polymer, while polymer chains relax and support gel-layer formation. Dissolved drug can then diffuse through the hydrated region. At the same time, gradual polymer erosion removes matrix material, so release may reflect both transport through the gel and loss of the surrounding structure.
Diffusion and erosion provide different pathways for drug release. Diffusion moves dissolved drug through the hydrated polymer, whereas erosion gradually reduces the matrix that contains it. Their combined contribution influences how consistently drug becomes available over time. Understanding this balance helps explain why hydrophilic matrices can moderate exposure rather than release the full dose immediately.
Gastrointestinal fluid supplies the aqueous environment needed for the matrix to begin hydrating. Water penetrates the polymer, polymer chains relax, and a gel layer develops at the dosage-form surface. Drug dissolution and movement can then proceed through that hydrated region, linking fluid contact directly to the onset and progression of controlled release.
Evaluation follows the release events created by fluid contact: observe water penetration, hydration and swelling, gel-layer development, drug dissolution, movement through the gel, and gradual polymer erosion. These stages provide a framework for interpreting how the dosage form releases drug over time and for assessing whether the matrix moderates exposure as intended.
This approach is valuable when formulation development aims to provide controlled drug release from an oral dosage form. By moderating release, it may help maintain drug exposure over time and reduce dosing frequency. Researchers can also use the platform to develop and evaluate formulations, while clinical pharmaceutics connects its release behavior with oral delivery goals.